NCT06972147 Prevalence and Description of FIRE (Food Induced Immediate Response of the Esophagus) in the Pediatric Population With Eosinophilic Esophagitis
| NCT ID | NCT06972147 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Angers |
| Condition | Eosinophilic Esophagitis |
| Study Type | OBSERVATIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-07-01 |
| Primary Completion | 2026-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 40 participants in total. It began in 2025-07-01 with a primary completion date of 2026-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A new clinical entity of eosinophilic esophagitis, Food Induced Immediate Response of the Esophagus or FIRE, has been described since 2020. Diagnostic criteria are not clearly established. Specific questioning is necessary for differential diagnosis, such as the oro-pharyngeal syndrome notably described in pollinics, or a mechanical blockage strictly speaking linked to esophagitis. The aim is to obtain epidemiological data on this entity.
Eligibility Criteria
Inclusion Criteria: * Patients over 6 and under 18 years of age at the time of inclusion * Follow-up in the allergology unit of Angers University Hospital for eosinophilic esophagitis Exclusion Criteria: * Patients or legal representative with severe communication or language comprehension difficulties * Patients or legal representatives objecting to study participation
Contact & Investigator
Anne HOPPE
PRINCIPAL INVESTIGATOR
University Hospital of Angers
Frequently Asked Questions
Who can join the NCT06972147 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 17 Years, studying Eosinophilic Esophagitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06972147 currently recruiting?
Yes, NCT06972147 is actively recruiting participants. Contact the research team at anne.hoppe@chu-angers.fr for enrollment information.
Where is the NCT06972147 trial being conducted?
This trial is being conducted at Angers, France, Lille, France.
Who is sponsoring the NCT06972147 clinical trial?
NCT06972147 is sponsored by University Hospital, Angers. The principal investigator is Anne HOPPE at University Hospital of Angers. The trial plans to enroll 40 participants.